ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 295642 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 295642; 2) Community: the network communities that were significantly associated with the response to NSC 295642; 3) Molecule: the relationships between components within communities and NSC 295642; 4) MDR: the compounds that were significantly associated with the NSC 295642.

NSC Compound Enrichment Correlation
NSC 645317 Sanguilutine pseudobase 0.0140755620492158 0.3096724
NSC 654379 ANTINEOPLASTIC-654379 0.0140755620492158 0.72127874
NSC 698065 Null 0.0140755620492158 -0.279393
NSC 732698 1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne 0.0140755620492158 0.26190705
NSC 734148 2-(4-Chloro-benzenesulfonylimino)-imidazolidine-1-carbodithi oic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4] thiadiazol-7-yl ester 0.0140755620492158 0.0036046724
NSC 736079 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine 0.0140755620492158 0.35296239
NSC 736081 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine 0.0140755620492158 0.27451672
NSC 621888 Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) 0.0152653588725065 0.22777267
NSC 668261 Null 0.0152653588725065 0.06058205
NSC 122621 Null 0.0152777849043084 0.23839032
Total:79  Current:29    [First] [Prev] [Next] [Last]